You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational ...
EFIV's future performance will likely be comparable to the S&P 500, though it may underperform in a lower rate environment favoring smaller-cap tech stocks. EFIV offers investors an option to ...
What I want to see from alternatives are comparable features and workflows ... toolkit that compares favorably with Adobe Acrobat. The interface and experience make using the software incredibly ...
The 5-year overall survival rate was 92.9% in the paclitaxel arm and 94.0% in the nab-paclitaxel arm. This phase 2/3 trial (NCT01779206) enrolled patients with HR-positive, HER2-negative ...